Venus Remedies Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 139.85 | 200.81 | 184.19 |
| Operating Expense | 119.20 | 171.49 | 149.63 |
| Net Profit | 11.69 | 14.79 | 24.08 |
| Net Profit Margin | 8.36 | 7.37 | 13.07 |
| Earning Per Share | 8.75 | 11.07 | 18.02 |
| EBIDTA | 21.34 | 27.49 | 36.66 |
| Effective Tax Rate | 17.92 | 28.00 | 21.35 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 139.85 |
| Operating Expense | 119.20 |
| Net Profit | 11.69 |
| Net Profit Margin | 8.36 |
| Earning Per Share | 8.75 |
| EBIDTA | 21.34 |
| Effective Tax Rate | 17.92 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 639.46 | 575.21 | 537.66 |
| Operating Expenses Annual | 569.46 | 514.32 | 476.14 |
| Operating Profit Annual | 100.69 | 72.21 | 71.70 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 11.10 | 16.51 | 22.61 |
| Net Profit Annual | 52.56 | 30.50 | 28.96 |
| Tax Annual | 26.51 | 16.15 | 11.36 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 639.46 |
| Operating Expenses Annual | 569.46 |
| Operating Profit Annual | 100.69 |
| Interest Annual | TBA |
| Depreciation | 11.10 |
| Net Profit Annual | 52.56 |
| Tax Annual | 26.51 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 48.51 | 20.07 | 42.83 |
| Cash Flow from Operations | 83.10 | 35.38 | 28.05 |
| Cash Flow from Investing | -76.20 | -6.94 | -50.81 |
| Cash Flow from Financing | TBA | TBA | TBA |
| Cash Flow at the End | 55.41 | 48.51 | 20.07 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 48.51 |
| Cash Flow from Operations | 83.10 |
| Cash Flow from Investing | -76.20 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 55.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 13.94 | 12.55 | 13.34 |
| PBIT Margin (%) | 10.56 | 8.11 | 7.50 |
| PBT Margin (%) | 10.56 | 8.11 | 7.50 |
| Net PROFIT Margin (%) | 8.22 | 5.30 | 5.39 |
| Return On Networth / Equity (%) | 8.10 | 6.18 | 6.24 |
| Return On Networth /Employed (%) | 11.75 | 8.61 | 7.89 |
| Return On Assets (%) | 9.12 | 5.62 | 5.66 |
| Total Debt / Equity (X) | 0.04 | 0.08 | 0.08 |
| Asset Turnover Ratio (%) | 1.11 | 1.06 | 1.05 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 13.94 |
| PBIT Margin (%) | 10.56 |
| PBT Margin (%) | 10.56 |
| Net PROFIT Margin (%) | 8.22 |
| Return On Networth / Equity (%) | 8.10 |
| Return On Networth /Employed (%) | 11.75 |
| Return On Assets (%) | 9.12 |
| Total Debt / Equity (X) | 0.04 |
| Asset Turnover Ratio (%) | 1.11 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 214.14 | 202.76 | 199.68 |
| Total Current Assets Annual | 435.75 | 361.00 | 318.19 |
| Non Current Assets Annual | 277.46 | 280.26 | 290.70 |
| Total Shareholders Funds Annual | 589.49 | 508.59 | 478.05 |
| Total Assets Annual | 713.21 | 641.26 | 608.89 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 214.14 |
| Total Current Assets Annual | 435.75 |
| Non Current Assets Annual | 277.46 |
| Total Shareholders Funds Annual | 589.49 |
| Total Assets Annual | 713.21 |
EPS (INR)
Expected
7.18
Reported
7.18
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
